STIM : 2-month performance

Neuronetics (STIM) began trading on the Nasdaq on 28 June 2018

Neuronetics is a company developing non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology.

• Sector: Healthcare
• Industry: Diagnostics & Research
• Full Time Employees: 145
• Headquarters: Malvern, PA
• Founded: 2003
• http://www.neuronetics.com

Opened for trading at $25 after pricing IPO at $19